NanoVibronix, Inc. (NAOV)

Market Cap	649.66K
Revenue (ttm)	2.66M
Net Income (ttm)	-5.61M
Shares Out	759.30K
EPS (ttm)	-15.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,229,751
Open	1.1800
Previous Close	1.1800
Day's Range	0.6669 - 1.5700
52-Week Range	0.6669 - 16.2500
Beta	2.04
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2025

About NAOV

NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing, and administration at home without the assistance of medical professionals. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, whi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: NAOV
• Website: https://www.nanovibronix.com

Financial Performance

In 2024, NanoVibronix's revenue was $2.56 million, an increase of 12.05% compared to the previous year's $2.28 million. Losses were -$3.71 million, -0.16% less than in 2023.